This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct 10;26(29):4849-50; author reply 4850-1.

doi: 10.1200/JCO.2008.18.7625. Epub 2008 Sep 8.

Gefitinib maintenance in stage III non-small-cell lung cancer

David J Stewart

PMID: 18779595
DOI: 10.1200/JCO.2008.18.7625

Comment

Gefitinib maintenance in stage III non-small-cell lung cancer

David J Stewart. J Clin Oncol. 2008.

. 2008 Oct 10;26(29):4849-50; author reply 4850-1.

doi: 10.1200/JCO.2008.18.7625. Epub 2008 Sep 8.

Author

David J Stewart

PMID: 18779595
DOI: 10.1200/JCO.2008.18.7625

No abstract available

PubMed Disclaimer

Comment on

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
Kelly K, Chansky K, Gaspar LE, Albain KS, Jett J, Ung YC, Lau DH, Crowley JJ, Gandara DR. Kelly K, et al. J Clin Oncol. 2008 May 20;26(15):2450-6. doi: 10.1200/JCO.2007.14.4824. Epub 2008 Mar 31. J Clin Oncol. 2008. PMID: 18378568 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information